Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.As of 26 May 2026, Vaishali Pharma share price is ₹7.06. The stock opened at ₹7.14, compared to its previous close of ₹7.00. During today's trading session, Vaishali Pharma share price moved in the range of ₹6.86 to ₹7.14, with an average price of ₹7.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹6.86 and a high of ₹7.14. On the performance front, Vaishali Pharma share price has declined by 20.79% over the last six months and is down 46.10% on a year-on-year basis.
The market capitalization of Vaishali Pharma is ₹91 Crs, with a P/E ratio of -175.0 and a dividend yield of 0.00%.